Supporting Patients During Incretin Mimetic Shortages
Updated: 05/01/25
Due to the glycemic, weight loss, and cardiovascular benefits of GLP-1 receptor agonists, many of these medications are experiencing short-term shortages. Here are some tips for supporting patients during medication shortages.
This one-page guide, developed by Heidi Diez, PharmD (first author), Jonathan Gabison, MD (co-first author), Lauren Oshman, MD, MPH, FAACP provides dosing and titration guidelines for switching between GLP-1 RA/GIPs during the national shortage in the United States, as well as functional tips for navigating medication shortages.
Providers: Please complete a feedback form to help us improve this tool (counts towards physician-level VBR requirement)
Tags: For Providers, Point-of-care, Created By MCT2D, Handout, Nephrology